The role of vitamin D deficiency in the incidence, progression, and complications of type 1 diabetes mellitus

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Chakhtoura, Marlene ^a   Azar, Sami T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

DIABETES CONTROL; DISEASE COURSE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INCIDENCE; INFANCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; NONHUMAN; PANCREAS CELL; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEASONAL VARIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84876525816     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/148673     Document Type: Review

References (121)

1. Harrison L. C., Honeyman M. C., Morahan G., Wentworth J. M., Elkassaby S., Colman P. G., Fourlanos S., Type 1 diabetes: lessons for other autoimmune diseases? Journal of Autoimmunity 2008 31 3 306 310 2-s2.0-56349115784 10.1016/j.jaut.2008.04.026
2. Craig M. E., Hattersley A., Donaghue K., Definition, epidemiology and classification of diabetes in children and adolescents. Pediatric Diabetes 2009 7 10, supplement 12 3 12 2-s2.0-33847740250 10.1111/j.1399-5448.2009.00568.x
3. Lammi N., Taskinen O., Moltchanova E., Notkola I. L., Eriksson J. G., Tuomilehto J., Karvonen M., A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996. Diabetologia 2007 50 7 1393 1400 2-s2.0-34249931881 10.1007/s00125-007-0690-4 (Pubitemid 46879019)
4. Forlenza G. P., Rewers M., The epidemic of type 1 diabetes: what is it telling us? Current Opinion in Endocrinology, Diabetes and Obesity 2011 18 4 248 251 2-s2.0-79960769096 10.1097/MED.0b013e32834872ce
5. Moroni L., Bianchi I., Lleo A., Geoepidemiology, gender and autoimmune disease. Autoimmunity Reviews 2012 11 A386 A392
6. Kriegel M. A., Manson J. E., Costenbader K. H., Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Seminars in Arthritis and Rheumatism 2011 40 6 512 531 2-s2.0-79955974612 10.1016/j.semarthrit.2010.07.009
7. Cutolo M., Pizzorni C., Sulli A., Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmunity Reviews 2011 11 84 87
8. Nagpal S., Na S., Rathnachalam R., Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews 2005 26 5 662 687 2-s2.0-23744437421 10.1210/er.2004-0002 (Pubitemid 41127276)
9. van Etten E., Mathieu C., Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. Journal of Steroid Biochemistry and Molecular Biology 2005 97 1-2 93 101 2-s2.0-27544499686 10.1016/j.jsbmb.2005.06.002 (Pubitemid 41546218)
10. Lee S., Clark S. A., Gill R. K., Christakos S., 1,25-Dihydroxyvitamin D3 and pancreatic β -cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994 134 4 1602 1610 2-s2.0-0028180723 10.1210/en.134.4.1602
11. Zella J. B., McCary L. C., DeLuca H. F., Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Archives of Biochemistry and Biophysics 2003 417 1 77 80 2-s2.0-0043063940 10.1016/S0003-9861(03)00338-2 (Pubitemid 36960051)
12. Giulietti A., Gysemans C., Stoffels K., Van Etten E., Decallonne B., Overbergh L., Bouillon R., Mathieu C., Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004 47 3 451 462 2-s2.0-1842844448 10.1007/s00125-004-1329-3 (Pubitemid 38491241)
13. Mathieu C., Laureys J., Sobis H., Vandeputte M., Waer M., Bouillon R., 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992 41 11 1491 1495 2-s2.0-0026649382
14. Casteels K. M., Mathieu C., Waer M., Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 1995 136 3 866 872 2-s2.0-0028847946
15. Gysemans C. A., Cardozo A. K., Callewaert H., Giulietti A., Hulshagen L., Bouillon R., Eizirik D. L., Mathieu C., 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005 146 4 1956 1964 2-s2.0-15444380329 10.1210/en.2004-1322 (Pubitemid 40396905)
16. Giarratana N., Penna G., Amuchastegui S., Mariani R., Daniel K. C., Adorini L., A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. Journal of Immunology 2004 173 4 2280 2287 2-s2.0-4043060025 (Pubitemid 39063083)
17. Gregori S., Giarratana N., Smiroldo S., Uskokovic M., Adorini L., A 1 α25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002 51 5 1367 1374 2-s2.0-0036020679 (Pubitemid 34826601)
18. Riachy R., Vandewalle B., Belaich S., Kerr-Conte J., Gmyr V., Zerimech F., d'Herbomez M., Lefebvre J., Pattou F., Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. Journal of Endocrinology 2001 169 1 161 168 2-s2.0-0035069930 10.1677/joe.0.1690161 (Pubitemid 32273225)
19. Emamaullee J. A., Davis J., Merani S., Toso C., Elliott J. F., Thiesen A., Shapiro A. M. J., Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009 58 6 1302 1311 2-s2.0-66649113381 10.2337/db08-1113
20. Arnson Y., Amital H., Shoenfeld Y., Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Annals of the Rheumatic Diseases 2007 66 9 1137 1142 2-s2.0-34548150136 10.1136/ard.2007.069831 (Pubitemid 47309727)
21. Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R., Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994 37 6 552 558 2-s2.0-0028357305 (Pubitemid 24162425)
22. Mathieu C., Waer M., Casteels K., Laureys J., Bouillon R., Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 1995 136 3 866 872 2-s2.0-0028847946
23. Overbergh L., Decallonne B., Waer M., Rutgeerts O., Valckx D., Casteels K. M., Laureys J., Bouillon R., Mathieu C., 1 α25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000 49 8 1301 1307 2-s2.0-0033624113 (Pubitemid 30624229)
24. Khoo A. L., Joosten I., Michels M., 1, 25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology 2011 134 4 459 468
25. Riachy R., Vandewalle B., Conte J. K., Moerman E., Sacchetti P., Lukowiak B., Gmyr V., Bouckenooghe T., Dubois M., Pattou F., 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 2002 143 12 4809 4819 2-s2.0-0036892143 10.1210/en.2002-220449 (Pubitemid 35397621)
26. Savinov A. Y., Tcherepanov A., Green E. A., Contribution of Fas to diabetes development. Proceedings of the National Academy of Sciences of the United States of America 2003 100 628 632 (Pubitemid 36126103)
27. Riachy R., Vandewalle B., Moerman E., Belaich S., Lukowiak B., Gmyr V., Muharram G., Kerr Conte J., Pattou F., 1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 2006 11 2 151 159 2-s2.0-33344468015 10.1007/s10495-006-3558-z (Pubitemid 43291016)
28. Nagpal S., Na S., Rathnachalam R., Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews 2005 26 5 662 687 2-s2.0-23744437421 10.1210/er.2004-0002 (Pubitemid 41127276)
29. Uitterlinden A. G., Fang Y., Van Meurs J. B. J., Pols H. A. P., Van Leeuwen J. P. T. M., Genetics and biology of vitamin D receptor polymorphisms. Gene 2004 338 2 143 156 2-s2.0-4143140820 10.1016/j.gene.2004.05.014 (Pubitemid 39094759)
30. Reis A. F., Hauache O. M., Velho G., Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes and Metabolism 2005 31 4, part 1 318 325 2-s2.0-25844433784 (Pubitemid 41391473)
31. Ramos-Lopez E., Jansen T., Ivaskevicius V., Kahles H., Klepzig C., Oldenburg J., Badenhoop K., Protection from type 1 diabetes by vitamin D receptor haplotypes. Annals of the New York Academy of Sciences 2006 1079 327 334 2-s2.0-33845706266 10.1196/annals.1375.050 (Pubitemid 44968742)
32. McDermott M. F., Ramachandran A., Ogunkolade B. W., Aganna E., Curtis D., Boucher B. J., Snehalatha C., Hitman G. A., Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997 40 8 971 975 2-s2.0-0030836013 10.1007/s001250050776 (Pubitemid 27316580)
33. Israni N., Goswami R., Kumar A., Rani R., Interaction of Vitamin D receptor with HLA DRB1-0301 in Type 1 diabetes patients from North India. PLoS ONE 2009 4 12 2-s2.0-77949510627 10.1371/journal.pone.0008023 e8023
34. Mohammadnejad Z., Ghanbari M., Ganjali R., Afshari J. T., Heydarpour M., Taghavi S. M., Fatemi S., Rafatpanah H., Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Molecular Biology Reports 2012 39 2 831 837 2-s2.0-79955813339 10.1007/s11033-011-0805-3
35. Martí G., Audí L., Esteban C., Oyarzábal M., Chueca M., Gussinyé M., Yeste D., Fernández-Cancio M., Andaluz P., Carrascosa A., Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus in two Spanish populations. Medicina Clinica 2004 123 8 286 290 2-s2.0-5644269232 (Pubitemid 39371526)
36. Nejentsev S., Cooper J. D., Godfrey L., Howson J. M. M., Rance H., Nutland S., Walker N. M., Guja C., Ionescu-Tirgovişte C., Savage D. A., Undlien D. E., Rønningen K. S., Tuomilehto-Wolf E., Tuomilehto J., Gillespie K. M., Ring S. M., Strachan D. P., Widmer B., Dunger D., Todd J. A., Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 2004 53 10 2709 2712 2-s2.0-4644246531 10.2337/diabetes.53.10.2709 (Pubitemid 39299283)
37. Guja C., Marshall S., Welsh K., Merriman M., Smith A., Todd J. A., Ionescu-Tîrgoviste C., The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population. Journal of Cellular and Molecular Medicine 2002 6 1 75 81 2-s2.0-0036361445 (Pubitemid 44133984)
38. Sahin S. B., Cetinkalp S., Erdogan M., Fas, Fas ligand, and vitamin D receptor fokI gene polymorphisms in patients with Type 1 diabetes mellitus in the aegean region of Turkey. Genet Test Mol Biomarkers 2012 16 10 1179 1183
39. Gogas Yavuz D., Keskin L., Kiyici S., Vitamin D receptor gene BsmI, FokI, ApaI, TaqI polymorphisms and bone mineral density in a group of Turkish type 1 diabetic patients. Acta Diabetologica 2011 48 4 329 336
40. Györffy B., Vásárhelyi B., Krikovszky D., Madácsy L., Tordai A., Tulassay T., Szabó A., Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus. European Journal of Endocrinology 2002 147 6 803 808 2-s2.0-0036929562 10.1530/eje.0.1470803 (Pubitemid 36032970)
41. Lemosa M., Fagulhab A., Coutinhoc E., Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Human Immunology 2008 69 134 138
42. Shimada A., Kanazawa Y., Motohashi Y., Yamada S., Maruyama T., Ikegami H., Awata T., Kawasaki E., Kobayashi T., Nakanishi K., Kawabata Y., Kurihara S., Uga M., Tanaka S., Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. Journal of Autoimmunity 2008 30 4 207 211 2-s2.0-42249115212 10.1016/j.jaut.2007.09.002 (Pubitemid 351551500)
43. Ban Y., Taniyama M., Yanagawa T., Yamada S., Maruyama T., Kasuga A., Ban Y., Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Medical Genetics 2001 2, article 7 2-s2.0-0011944607 10.1186/1471-2350-2-7 (Pubitemid 38692949)
44. Turpeinen H., Hermann R., Vaara S., Laine A. P., Simell O., Knip M., Veijola R., Ilonen J., Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. European Journal of Endocrinology 2003 149 6 591 596 2-s2.0-0347989271 10.1530/eje.0.1490591 (Pubitemid 38054705)
45. Fichna M., Zurawek M., Januszkiewicz-Lewandowska D., Fichna P., Nowak J., PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. International Journal of Immunogenetics 2010 37 5 367 372 2-s2.0-78651112432 10.1111/j.1744-313X.2010.00935.x
46. Boraska V., Škrabić V., Zeggini E., Groves C. J., Buljubašić M., Peruzović M., Zemunik T., Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in the population of South Croatia. Journal of Human Genetics 2008 53 3 210 214 2-s2.0-40049106203 10.1007/s10038-007-0234-2
47. Zemunik T., Škrabić V., Boraska V., Diklić D., Terzić I. M., Čapkun V., Peruzović M., Terzić J., Fokl polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. Journal of Molecular Diagnostics 2005 7 5 600 604 2-s2.0-27744538935 (Pubitemid 41601511)
48. Mory D. B., Rocco E. R., Miranda W. L., Kasamatsu T., Crispim F., Dib S. A., Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to β -cell autoimmunity and to remaining β -cell function. Human Immunology 2009 70 6 447 451 2-s2.0-67349106780 10.1016/j.humimm.2009.03.007
49. Mimbacas A., Trujillo J., Gascue C., Javiel G., Cardoso H., Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genetics and Molecular Research 2007 6 3 534 542 2-s2.0-36048936898 (Pubitemid 350096888)
50. Fassbender W. J., Goertz B., Weismüller K., Steinhauer B., Stracke H., Auch D., Linn T., Bretzel R. G., VDR gene polymorphisms are overrepresented in German patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Hormone and Metabolic Research 2002 34 6 330 337 2-s2.0-0035988662 10.1055/s-2002-33262 (Pubitemid 34761718)
51. Pani M. A., Knapp M., Donner H., Braun J., Baur M. P., Usadel K. H., Badenhoop K., Vitamin D receptor allele combinations influence genetic susceptibility to 1 diabetes in Germans. Diabetes 2000 49 3 504 507 2-s2.0-0034101764 (Pubitemid 30131799)
52. Ramos-Lopez E., Jansen T., Ivaskevicius V., Kahles H., Klepzig C., Oldenburg J., Badenhoop K., Protection from type 1 diabetes by vitamin D receptor haplotypes. Annals of the New York Academy of Sciences 2006 1079 327 334 2-s2.0-33845706266 10.1196/annals.1375.050 (Pubitemid 44968742)
53. Panierakis C., Goulielmos G., Mamoulakis D., Petraki E., Papavasiliou E., Galanakis E., Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clinical Immunology 2009 133 2 276 281 2-s2.0-70349770528 10.1016/j.clim.2009.08.004
54. Ogunkolade B. W., Boucher B. J., Prahl J. M., Bustin S. A., Burrin J. M., Noonan K., North B. V., Mannan N., McDermott M. F., Deluca H. F., Hitman G. A., Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002 51 7 2294 2300 2-s2.0-0036303244 (Pubitemid 34729038)
55. Chang T. J., Lei H. H., Yeh J. I., Chiu K. C., Lee K. C., Chen M. C., Tai T. Y., Chuang L. M., Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clinical Endocrinology 2000 52 5 575 580 2-s2.0-0034038972 10.1046/j.1365-2265.2000. 00985.x (Pubitemid 30337082)
56. García D., Angel B., Carrasco E., Albala C., Santos J. L., Pérez-Bravo F., VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Research and Clinical Practice 2007 77 1 134 140 2-s2.0-34247147575 10.1016/j.diabres.2006.10.018 (Pubitemid 46590474)
57. Bianco M. G., Minicucci L., Calevo M. G., Lorini R., Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? European Journal of Endocrinology 2004 151 5 641 642 2-s2.0-9444290728 10.1530/eje.0.1510641 (Pubitemid 39562520)
58. Ponsonby A. L., Pezic A., Ellis J., Morley R., Cameron F., Carlin J., Dwyer T., Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. American Journal of Epidemiology 2008 168 4 358 365 2-s2.0-49449099724 10.1093/aje/kwn142
59. Van Etten E., Verlinden L., Giulietti A., Ramos-Lopez E., Branisteanu D. D., Ferreira G. B., Overbergh L., Verstuyf A., Bouillon R., Roep B. O., Badenhoop K., Mathieu C., The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. European Journal of Immunology 2007 37 2 395 405 2-s2.0-33947726858 10.1002/eji.200636043 (Pubitemid 46915579)
60. Zhang J., Li W., Liu J., Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: an update by meta-analysis. Molecular and Cellular Endocrinology 2012 355 135 142
61. Janner M., Ballinari P., Mullis P. E., Flück C. E., High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Medical Weekly 2010 140 w13091 2-s2.0-79952066865
62. Bener A., Alsaied A., Al-Ali M., Al-Kubaisi A., Basha B., Abraham A., Guiter G., Mian M., High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetologica 2009 46 3 183 189 2-s2.0-69849094438 10.1007/s00592-008-0071-6
63. Borkar V. V., Devidayal V. S., Bhalla A. K., Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatric Diabetes 2010 11 5 345 350 2-s2.0-77955244584 10.1111/j.1399-5448.2009.00589.x
64. Svoren B. M., Volkening L. K., Wood J. R., Laffel L. M. B., Significant vitamin D deficiency in youth with type 1 diabetes mellitus. Journal of Pediatrics 2009 154 1 132 134 2-s2.0-57249096582 10.1016/j.jpeds.2008.07.015
65. Pozzilli P., Manfrini S., Crinò A., Low levels of 25-hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Hormone and Metabolic Research 2005 37 11 680 683 (Pubitemid 41810490)
66. Greer R. M., Portelli S. L., Hung B. S., Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatric Diabetes 2012 14 1 31 41 10. 1111/j. 1399-5448. 2012. 00890.x
67. Hamed E. A., Faddan N. H., Elhafeez H. A., Parathormone-25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr Diabete 2011 12 6 536 546
68. Rodland O., Markestad T., Aksnes L., Aarskog D., Plasma concentration of vitamin D metabolites during puberty of diabetic children. Diabetologia 1985 28 9 663 666 2-s2.0-0022125677 (Pubitemid 16226403)
69. Littorin B., Blom P., Schölin A., Arnqvist H. J., Blohmé G., Bolinder J., Ekbom-Schnell A., Eriksson J. W., Gudbjörnsdottir S., Nyström L., Östman J., Sundkvist G., Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006 49 12 2847 2852 2-s2.0-33750915052 10.1007/s00125-006-0426-x (Pubitemid 44730286)
70. Bierschenk L., Alexander J., Wasserfall C., Haller M., Schatz D., Atkinson M., Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009 32 11 1977 1979 2-s2.0-70449347410 10.2337/dc09-1089
71. Di Cesar D. J., Ploutz-Snyder R., Weinstock R. S., Moses A. M., Vitamin D deficiency is more common in type 2 than in type 1 diabetes [6]. Diabetes Care 2006 29 1 174 2-s2.0-33644874186 (Pubitemid 44033461)
72. DeLuca H. F., Overview of general physiologic features and functions of vitamin D. The American Journal of Clinical Nutrition 2004 80 6, supplement 1689S 1696S
73. Staples J. A., Ponsonby A. L., Lim L. L. Y., McMichael A. J., Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: iatitude, regional ultraviolet radiation, and disease prevalence. Environmental Health Perspectives 2003 111 4 518 523 2-s2.0-0038070245 (Pubitemid 36546533)
74. Nystrom L., Dahlquist G., Ostman J., Wall S., Arnqvist H., Blohme G., Lithner F., Littorin B., Schersten B., Wibell L., Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: indications of climatological determinants for age at onset. International Journal of Epidemiology 1992 21 2 352 358 2-s2.0-0026559302
75. Yang Z., Wang K., Tianlin L. I., Sun W., Li Y., Chang Y. F., Dorman J. S., LaPorte R. E., Childhood diabetes in China: enormous variation by place and ethnic group. Diabetes Care 1998 21 4 525 529 2-s2.0-0031944357 10.2337/diacare.21.4.525 (Pubitemid 28172928)
76. Joner G., Stene L. C., Søvik O., Nationwide, prospective registration of type 1 diabetes in children aged <15 years in Norway 1989-1998: no increase but significant regional variation in incidence. Diabetes Care 2004 27 7 1618 1622 2-s2.0-3042800911 10.2337/diacare.27.7.1618 (Pubitemid 38857435)
77. Variation and trends in incidence of childhood diabetes in Europe. The Lancet 2000 355 9207 873 876 2-s2.0-0034635768 10.1016/S0140-6736(99)07125-1 (Pubitemid 30137666)
78. Casu A., Pascutto C., Bernardinelli L., Songini M., Bayesian approach to study the temporal trend and the geographical variation in the risk of type 1 diabetes: the Sardinian Conscript type 1 diabetes registry. Pediatric Diabetes 2004 5 1 32 38 2-s2.0-1842832865 10.1111/j.1399-543X.2004.00037.x (Pubitemid 38489443)
79. Mohr S. B., Garland C. F., Gorham E. D., Garland F. C., The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008 51 8 1391 1398 2-s2.0-48149085565 10.1007/s00125-008-1061-5
80. Merriman T. R., Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency. Diabetes Research and Clinical Practice 2009 83 2 149 156 2-s2.0-58249123682 10.1016/j.diabres.2008.11.010
81. Vaiserman A. M., Carstensen B., Voitenko V. P., Tronko M. D., Kravchenko V. I., Khalangot M. D., Mechova L. V., Seasonality of birth in children and young adults (0-29 years) with type 1 diabetes in Ukraine. Diabetologia 2007 50 1 32 35 2-s2.0-33845934454 10.1007/s00125-006-0456-4 (Pubitemid 46035849)
82. Samuelsson U., Johansson C., Ludvigsson J., Month of birth and risk of developing insulin dependent diabetes in south east Sweden. Archives of Disease in Childhood 1999 81 2 143 146 2-s2.0-0032799719 (Pubitemid 29349992)
83. Kalliora M. I., Vazeou A., Delis D., Bozas E., Thymelli I., Bartsocas C. S., Seasonal variation of type 1 diabetes mellitus diagnosis in Greek children. Hormones 2011 10 1 67 71 2-s2.0-79951483423
84. Roche E. F., Lewy H., Hoey H. M. C. V., Laron Z., Differences between males and females in the seasonality of birth and month of clinical onset of disease in chilren with type 1 diabetes mellitus in Ireland. Journal of Pediatric Endocrinology and Metabolism 2003 16 5 779 782 2-s2.0-0141797625 (Pubitemid 37259161)
85. Ursic-Bratina N., Battelino T., Kržišnik C., Laron-Kenet T., Ashkenazi I., Laron Z., Seasonality of birth in children (0-14 years) with type 1 diabetes mellitus in Slovenia. Journal of Pediatric Endocrinology and Metabolism 2001 14 1 47 52 2-s2.0-0035114515 (Pubitemid 32166451)
86. Kordonouri O., Shuga N., Lewy H., Ashkenazi I., Laron Z., Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in Berlin differs from the general population. European Journal of Pediatrics 2002 161 5 291 292 2-s2.0-0036245357 10.1007/s00431-002-0941-9 (Pubitemid 34492693)
87. Jongbloet P. H., Groenewoud H. M., Hirasing R. A., Van Buuren S., Seasonality of birth in patients with childhood diabetes in The Netherlands. Diabetes Care 1998 21 1 190 191 2-s2.0-0031613229
88. Rothwell P. M., Staines A., Smail P., Wadsworth E., McKinney P., Seasonality of birth of patients with childhood diabetes in Britain. British Medical Journal 1996 312 7044 1456 1457 2-s2.0-0029895105 (Pubitemid 26170619)
89. Willis J. A., Scott R. S., Darlow B. A., Lewy H., Ashkenazi I., Laron Z., Seasonality of birth and onset of clinical disease in children and adolescents (0-19 years) with type 1 diabetes mellitus in Canterbury, New Zealand. Journal of Pediatric Endocrinology and Metabolism 2002 15 5 645 647 2-s2.0-0036013249 (Pubitemid 34704824)
90. Songini M., Casu A., Ashkenazi I., Laron Z., Seasonality of birth in children (0-14 years) and young adults (0-29 years) with type 1 diabetes mellitus in Sardinia differs from that in the general population. Journal of Pediatric Endocrinology and Metabolism 2001 14 6 781 783 2-s2.0-0034961132 (Pubitemid 32591144)
91. Rothwell P. M., Gutnikov S. A., McKinney P. A., Schober E., Ionescu-Tirgoviste C., Neu A., Seasonality of birth in children with diabetes in Europe: multicentre cohort study. British Medical Journal 1999 319 7214 887 888 2-s2.0-0033517504 (Pubitemid 29457415)
92. Bock T., Pedersen C. R., Volund A., Pallesen C. S., Buschard K., Perinatal determinants among children who later develop IDDM. Diabetes Care 1994 17 10 1154 1157 2-s2.0-0027968757 (Pubitemid 24307450)
93. El Baba K., Zantout M. S., Arabi A., Azar S. T., Seasonal variations of glucose control in Lebanese patients with type 1 diabetes. Biological Rhythm Research 2010 41 2 91 97 2-s2.0-77951040512 10.1080/09291010802594471
94. El Baba K., Zantout M., Akel R., Azar S., Seasonal variation in vitamin D and HbA(1c) levels in patients with type 1 diabetes mellitus in the Middle East. International Journal of General Medicine 2011 4 635 638
95. Laron Z., Lewy H., Wilderman I., Casu A., Willis J., Redondo M. J., Libman I., White N., Craig M., Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Israel Medical Association Journal 2005 7 6 381 384 2-s2.0-20844446320 (Pubitemid 40862042)
96. Vitamin D supplement in early childhood and risk for Type I (insulin- dependent) diabetes mellitus. Diabetologia 1999 42 1 51 54 2-s2.0-0032939358 10.1007/s001250051112 (Pubitemid 29039737)
97. Hyppönen E., Läärä E., Reunanen A., Järvelin M. R., Virtanen S. M., Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. The Lancet 2001 358 9292 1500 1503 (Pubitemid 33055701)
98. Stene L. C., Ulriksen J., Magnus P., Joner G., Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000 43 9 1093 1098 2-s2.0-0033811930 10.1007/s001250051499
99. Stene L. C., Joner G., Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. American Journal of Clinical Nutrition 2003 78 6 1128 1134 2-s2.0-0642307067 (Pubitemid 39663453)
100. Fronczak C. M., Barón A. E., Chase H. P., Ross C., Brady H. L., Hoffman M., Eisenbarth G. S., Rewers M., Norris J. M., In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 2003 26 12 3237 3242 2-s2.0-0345707497 10.2337/diacare.26.12.3237 (Pubitemid 37466881)
101. Tenconi M. T., Devoti G., Comelli M., Pinon M., Capocchiano A., Calcaterra V., Pretti G., Bobba L., Buratti A., Cacciabue L., De Cata P., Lorena M., Lovati E., Mezzogori C., Rea A., Rebagliati M., Romagnoli P., Romani M., Solerte B., Tognin T., Vailati A., Major childhood infectious diseases and other determinants associated with type 1 diabetes: a case-control study. Acta Diabetologica 2007 44 1 14 19 2-s2.0-33947239707 10.1007/s00592-007-0235-9 (Pubitemid 46426957)
102. Brekke H. K., Ludvigsson J., Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatric Diabetes 2007 8 1 11 14 2-s2.0-33847771141 10.1111/j.1399-5448.2006.00223.x (Pubitemid 46390381)
103. Marjamäki L., Niinistö S., Kenward M. G., Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010 53 8 1599 1607
104. Zipitis C. S., Akobeng A. K., Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Archives of Disease in Childhood 2008 93 6 512 517 2-s2.0-44149111801 10.1136/adc.2007.128579 (Pubitemid 352025770)
105. Antico A., Tampoia M., Tozzoli R., Bizzaro N., Can supplementation with Vitamin D reduce the risk or modify the course of autoimmune diseases? A systamatic review of the literature. Autoimmunity Reviews 2012 12 127 136
106. Nyomba B. L., Verhaeghe J., Thomasset M., Lissens W., Bouillon R., Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 1989 124 2 565 572 2-s2.0-0024503410 (Pubitemid 19057039)
107. Thrailkill K. M., Jo C. H., Cockrell G. E., Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? The Journal of Clinical Endocrinology & Metabolism 2011 96 1 142 149
108. Huynh T., Greer R. M., Nyunt O., Bowling F., Cowley D., Leong G. M., Cotterill A. M., Harris M., The association between ketoacidosis and 25(OH)-vitamin D3 levels at presentation in children with type 1 diabetes mellitus. Pediatric Diabetes 2009 10 1 38 43 2-s2.0-59149083921 10.1111/j.1399-5448.2008.00439.x
109. Devaraj S., Yun J. M., Duncan-Staley C. R., Jialal I., Low vitamin d levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. American Journal of Clinical Pathology 2011 135 3 429 433 2-s2.0-79954432995 10.1309/AJCPJGZQX42BIAXL
110. Verrotti A., Basciani F., Carle F., Morgese G., Chiarelli F., Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria. Journal of Endocrinological Investigation 1999 22 3 198 202 2-s2.0-0032932913 (Pubitemid 29158639)
111. Judd S., Tangpricha V., Vitamin D., Deficiency and risk for cardiovascular disease. Circulation 2008 117 4 503 511
112. Pitocco D., Crinò A., Di Stasio E., Manfrini S., Guglielmi C., Spera S., Beretta Anguissola G., Visalli N., Suraci C., Matteoli M. C., Patera I. P., Cavallo M. G., Bizzarri C., Pozzilli P., The effects of calcitriol and nicotinamide on residual pancreatic β -cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabetic Medicine 2006 23 8 920 923 2-s2.0-33746580370 10.1111/j.1464-5491.2006.01921.x (Pubitemid 44141083)
113. Bizzarri C., Pitocco D., Napoli N., Di Stasio E., Maggi D., Manfrini S., Suraci C., Cavallo M. G., Cappa M., Ghirlanda G., Pozzilli P., Altomare M., Astorri E., Barchetta I., Benevento D., Beretta Anguissola G., Buzzetti R., Capizzi M., Cassone Faldetta M. R., Cipolloni L., Cipponeri E., Costantino F., Crinò A., Fioriti E., Guglielmi C., Lauria A., Maurizi A. R., Moretti C., Morbiducci L., Palermo A., Patera P., Portuesi R., Scrocca R., Spera S., Strollo R., Tubili C., Tuccinardi D., Valente L., Visalli N., No protective effect of calcitriol on β -cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010 33 9 1962 1963 2-s2.0-79951655976 10.2337/dc10-0814
114. Li X., Liao L., Yan X., Huang G., Lin J., Lei M., Wang X., Zhou Z., Protective effects of 1- α -hydroxyvitamin D3 on residual β -cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes/Metabolism Research and Reviews 2009 25 5 411 416 2-s2.0-70350680951 10.1002/dmrr.977
115. Aljabri K. S., Bokhari S. A., Khan M. J., Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Annals of Saudi Medicine 2010 30 6 454 508 2-s2.0-78649392064 10.4103/0256-4947.72265
116. Wagner C. L., Greer F. R., Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008 122 5 1142 1152 2-s2.0-58149171483 10.1542/peds.2008-1862
117. Ross A. C., Manson J. E., Abrams S. A., Aloia J. F., Brannon P. M., Clinton S. K., Durazo-Arvizu R. A., Gallagher J. C., Gallo R. L., Jones G., Kovacs C. S., Mayne S. T., Rosen C. J., Shapses S. A., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism 2011 96 1 53 58 2-s2.0-78650886291 10.1210/jc.2010-2704
118. Harris S., Can vitamin D supplementation in infancy prevent type 1 diabetes? Nutrition Reviews 2002 60 4 118 121 2-s2.0-0036226435 10.1301/00296640260085868 (Pubitemid 34309548)
119. Holick M., Binkley N., Bischoff-Ferrari H., Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2011 96 7 1911 1930
120. Penna G., Adorini L., 1 α25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. Journal of Immunology 2000 164 5 2405 2411 2-s2.0-0034161714 (Pubitemid 30115468)
121. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B. E., Cin E. D., Allavena P., Di Carlo V., Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. Journal of Immunology 2000 164 9 4443 4451 2-s2.0-0034178251 (Pubitemid 30238038)